June 2, 2020 / 10:11 AM / a month ago

BRIEF-Brainstorm Reports Phase 3 Trial Remains On Track For Topline Data In Q4-2020

June 2 (Reuters) - Brainstorm Cell Therapeutics Inc :

* BRAINSTORM ANNOUNCES THAT PIVOTAL PHASE 3 TRIAL REMAINS ON TRACK FOR TOPLINE DATA IN Q4-2020

* BRAINSTORM CELL THERAPEUTICS - COMPLETION OF ALL DOSING IN NUROWNPHASE 3 TRIAL EXPECTED BY JULY 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below